Douglas S. Scherr

Urology
525 E 68th St # 900
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 211 publications

Reply by Authors.

Reply by Authors.

Journal: Urology practice
Published: September 01, 2026

National Patterns and Predictors of Perioperative Intravesical Chemotherapy Use Following Nephroureterectomy for Upper Tract Urothelial Carcinoma.

National Patterns and Predictors of Perioperative Intravesical Chemotherapy Use Following Nephroureterectomy for Upper Tract Urothelial Carcinoma.

Journal: Urology practice
Published: July 02, 2026

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

Journal: Science advances
Published: June 26, 2026

Urolithiasis in patients with cancer.

Urolithiasis in patients with cancer.

Journal: Nature reviews. Urology
Published: June 03, 2026

The Contemporary Pattern of Radical Cystectomy in the Treatment of High-Grade Non-Muscle Invasive Bladder Cancer.

The Contemporary Pattern of Radical Cystectomy in the Treatment of High-Grade Non-Muscle Invasive Bladder Cancer.

Journal: Clinical genitourinary cancer
Published: May 04, 2026

Natural language processing models for patient-centered summaries of prostatectomy pathology reports.

Natural language processing models for patient-centered summaries of prostatectomy pathology reports.

Journal: Scientific reports
Published: March 06, 2026

Effective PD-1 checkpoint blockade in bladder cancer model requires tumor-draining lymph nodes and lymphocyte trafficking.

Effective PD-1 checkpoint blockade in bladder cancer model requires tumor-draining lymph nodes and lymphocyte trafficking.

Journal: Urologic oncology
Published: February 17, 2026

19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder.

19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder.

Journal: Cancer genetics
Published: January 25, 2026

Persistent Sex Disparities in Bladder Cancer Diagnosis: An Analysis of National Trends From 2012 to 2021.

Persistent Sex Disparities in Bladder Cancer Diagnosis: An Analysis of National Trends From 2012 to 2021.

Journal: Urology practice
Published: October 10, 2025

Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer.

Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer.

Journal: JU open plus
Published: October 01, 2025

SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasia.

SPINK1 immunohistochemistry: An ancillary tool to diagnose urothelial carcinoma in situ and urothelial dysplasia.

Journal: Pathology, research and practice
Published: July 22, 2025

Unequal Access to Novel Systemic Therapies for Bladder Cancer: A Global Analysis of Clinical Trials of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates.

Unequal Access to Novel Systemic Therapies for Bladder Cancer: A Global Analysis of Clinical Trials of Immune Checkpoint Inhibitors and Antibody-Drug Conjugates.

Journal: Current urology reports
Published: April 24, 2025
Showing 1-12 of 211

Last Updated: 09/26/2026